Elaine Castellanos, VP, Chief Accounting Officer at REATA PHARMACEUTICALS INC (RETA), sold 11,546 shares at $142.50 ($1.7M) on 2021-06-09, disclosed to the SEC on 2021-06-09.
Open-market sale of $1.7M RETA by VP, Chief Accounting Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $146.47 | 910 | $133K | 8.1% |
| 2 | $146.47 | 910 | $133K | 8.1% |
| 3 | $147.16 | 636 | $94K | 5.7% |
| 4 | $147.16 | 636 | $94K | 5.7% |
| 5 | $141.86 | 7,900 | $1.1M | 67.8% |
| 6 | $142.50 | 554 |
| $79K |
| 4.8% |
| Total | $143.20 avg | 11,546 | $1.7M | 100% |
| Filing → |
| RETA | SELL | 2020-06-01 | $288K | — | Filing → |
| RETA | SELL | 2020-03-02 | $389K | — | Filing → |
| RETA | SELL | 2019-12-03 | $388K | — | Filing → |